期刊文献+

淡豆豉煎剂对高脂血症大鼠主动脉晚期糖化终末产物的抑制作用 被引量:5

Effects of Sojae Semen Praeparatumi(淡豆豉) on advanced glycosylation end products(AGEs) in aortae and serum levels of lipid peroxide in hyperlipemia Rats
下载PDF
导出
摘要 目的:探讨淡豆豉对高脂血症大鼠晚期糖化终末产物(AGEs)和血清脂质过氧化物的影响。方法:高脂饮食制备大鼠高脂血症模型,造型同时给予淡豆豉水煎剂治疗,于第13周末最后一次给药禁食24小时后取血和主动脉,分别测定主动脉AGEs含量、血脂和血清过氧化物含量。结果:与正常组比较,高脂血症模型组主动脉AGEs、血清胆固醇(TC)和丙二醛(MDA)含量均明显升高;高密度脂蛋白-胆固醇(HDL-C)和超氧化物歧化酶(SOD)活性均显著降低。淡豆豉各组主动脉AGEs、血清MDA、TC均明显降低;血清HDL-C和SOD活性均显著升高。结论:淡豆豉通过降低高脂血症大鼠主动脉AGEs含量、降低大鼠血清MDA水平、提高SOD活性、调节血脂,预防和减少动脉粥样硬化的发生。 Objective: To investigate effects of Sojae Semen praeparatumi(SSP) on advanced glycosylation end products (AGEs), lipid peroxide of hyperlipemia rats. Methods: Hyperlipemia models were induced by feeding excess of fat and lipids in rats, the levels of aortic AGEs, lipids and serum lipid peroxide were detected after 13 weeks of treatment. Results: The aortic AGEs, serum cholesterol(TC), and malondialdehyde (MDA) of the SSP group were lower and the levels of high density lipoprotein-cholesterol(HDL-C), and activity of superoxide dismutase (SOD) were higher. Conclusion: The results indicated that SSP could decrease aortic AGEs, serum MDA, blood lipid and enhance SOD activity therefor it maybe helpful in cardiovascular system.
出处 《中药药理与临床》 CAS CSCD 北大核心 2006年第3期101-103,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 北京联合大学中青年骨干教师资助计划项目
关键词 淡豆豉 晚期糖化终末产物(AGEs) 脂质过氧化物 高脂血症 Sojae Semen Praeparatumi (淡豆鼓) AGEs Lipid peroxide hyperlipemia
  • 相关文献

参考文献6

二级参考文献28

  • 1葛勇,张家庆,周云平.水飞蓟宾、槲皮素对糖尿病鼠主动脉胶原和血清β脂蛋白非酶糖化的阻断作用[J].中国糖尿病杂志,1994,2(1):38-41. 被引量:6
  • 2葛勇,张家庆,周云平.水飞蓟宾及槲皮素对体外白蛋白非酶糖化的抑制作用[J].第二军医大学学报,1995,16(4):333-336. 被引量:33
  • 3孙军明,丁安林,常汝镇,东惠茹.中国大豆异黄酮含量的初步分析[J].中国粮油学报,1995,10(4):51-54. 被引量:60
  • 4希雨.Novogen公司大力开发植物雌激素产品[J].国外医药,植物药分册,2000,15(1):34-34.
  • 5Ann Vincent, M D. Soy Isofiavones: Are They Useful in Menopause[J]. Mayo Clin Proc, 2000, 75:1174-1184.
  • 6Coward-L. Chemical modification of isoflavones in soyfoods during cooking and processing[J]. Am-J-Clin-Nutr, 1998,68(6 Suppl): 1486S-1491S.
  • 7Browlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low density lipoprotein[J]. Diabetes, 1985, 34(9): 938-940.
  • 8Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine[J].Diabetes, 1992, 41(1): 26-29.
  • 9Kiuchi K, Nejima J, Takano T, Ohta M, et al. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients[J]. Heart, 2001, 85(1): 87-91.
  • 10Hadley J, Malik N, Meek K. Collagen as a model system to investigate the use of aspirin as an inhibitor of protein glycation and crosslinking[J]. Micron, 2001, 32(3): 307-15.

共引文献31

同被引文献36

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部